Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents

Medicine & Life Sciences

• Point-of-Care Systems 100%
• Antipsychotic Agents 81%
• Outpatients 66%
• Abdominal Obesity 15%
• Body Mass Index 14%
• Hyperlipidemias 13%
• Waist Circumference 13%
• Hypertension 13%
• Checklist 13%
• Glucose 12%
• African Americans 12%
• Psychiatry 10%
• Point-of-Care Testing 9%
• Prediabetic State 8%
• Vital Signs 7%
• Major Depressive Disorder 7%
• Pharmacists 6%
• Bipolar Disorder 6%
• Hispanic Americans 6%
• Psychotic Disorders 6%
• Metabolic Syndrome 6%
• Hip 5%
• Schizophrenia 5%
• Diabetes Mellitus 5%
• Alcohols 5%
• Smoking 4%
• Nurses 4%
• Cohort Studies 4%
• Cross-Sectional Studies 4%
• Demography 4%
• Blood Pressure 4%
• Weights and Measures 4%
• Drug Therapy 4%
• Population 2%